• Uno K, Nishizawa D, Seo S, Takayama K, Matsumura S, Sakai N, Ohi K, Nabeshima T, Hashimoto R, Ozaki N, Hasegawa J, Sato N, Tanioka F, Sugimura H, Fukuda KI, Higuchi S, Ujike H, Inada T, Iwata N, Sora I, Iyo M, Kondo N, Won MJ, Naruse N, Uehara-Aoyama K, Itokawa M, Yamada M, Ikeda K, Miyamoto Y, Nitta A.: The piccolo intronic single nucleotide polymorphism rs13438494 regulates dopamine and serotonin uptake and shows associations with dependence-like behavior in genomic association study. Cur. Mol. Med. 2015, 15: 265-274.

 

• Ohara M, Tomoda F, Koike T, Liu H, Uno K, Nitta A, Inoue H: Pubertal administration of antiserum against nerve growth factor regresses renal vascular remodeling in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 2015, 42: 687-694.

 

• Sumi K, Uno K, Matsumura S, Miyamoto Y, Furukawa-Hibi Y, Muramatsu S, Nabeshima T, Nitta A: Induction of neuronal axon outgrowth by Shati/Nat8l by energy metabolism in mice cultured neurons. Neuroreport. 2015, 26: 740-746.

 

• Toriumi K, Mamiya T, Song Z, Honjo T, Watanabe H, Tanaka J,　Kondo M, Mouri A, Kim HC, Nitta A, Fukushima T, Nabeshima T: Deletion of SHATI/NAT8L decreases the N-acetylaspartate content in the brain and induces behavioral deficits, which can be ameliorated by administering N-acetylaspartate. Eur Neuropsychopharmacol.  2015, 25: 2108-2117.

• Nakayama C, Oshima T, Kato A, Nitta A: Development of a communication learning program for pharmacists. Jap J Pharm Health Care Sci. 2015, 41: 80-92.

　

• Tanabe K, Wada J, Ohkubo J, Nitta A, Ikezaki T, Takeuchi M, Handa A, Tanaka M, Murakami N, Kashii T, Kitazawa H. Stability of octreotide acetate decreases in a sodium bisulfate concentration-dependent manner: compatibility study with morphine and metoclopramide injections. Eur J Hosp Pharm Sci Pract. 2015, 22: 171-175.